Opioid Partial Agonist
Extended-Release Buprenorphine +1 More for Opioid Use Disorder
This trial is testing to see if an injectable extended-release form of buprenorphine (Sublocade) is more helpful than the standard sublingual buprenorphine therapy in treating opiate use for individuals testing positive for fentanyl and related high potency drugs (HPSO).